Early cost-effectiveness analysis of risk-based selection strategies for adjuvant treatment in stage II colon cancer: the potential value of prognostic molecular markers

Early cost-effectiveness analysis of risk-based selection strategies for adjuvant treatment in stage II colon cancer: the potential value of prognostic molecular markers

BACKGROUND: To explore the potential value of Consensus Molecular Subtypes (CMS) in stage II colon cancer (CC) treatment selection, we carried out an early cost-effectiveness assessment of a CMS-based strategy for adjuvant chemotherapy. METHODS: We used a Markov cohort model to evaluate three select...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Jongeneel, Gabrielle, Greuter, Marjolein J.E., Kunst, Natalia, van Erning, Felice N., Koopman, Miriam, Medema, Jan P., Vermeulen, Louis, Ijzermans, Jan N.M., Vink, Geraldine R., Punt, Cornelis J.A., Coupé, Veerle M.H.
Formaat: Text
Taal:Engels
Gepubliceerd in: 2021
Onderwerpen:
Article
Online toegang:https://pmc.ncbi.nlm.nih.gov/articles/PMC7611620/
https://pubmed.ncbi.nlm.nih.gov/34162659
http://dx.doi.org/10.1158/1055-9965.EPI-21-0078
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

https://pmc.ncbi.nlm.nih.gov/articles/PMC7611620/
https://pubmed.ncbi.nlm.nih.gov/34162659
http://dx.doi.org/10.1158/1055-9965.EPI-21-0078

Gelijkaardige items